Skip to content

    Rallis India

    RALLISGood
    Chemicals·15 Jul 2025
    Management Summary

    Rallis India delivered a strong Q1 FY26 performance, with significant revenue and profit growth driven by robust volume expansion across its Crop Care and Seed businesses. The company benefited from improving market sentiments, favorable monsoon, and strategic product launches, despite some challenges in specific crop segments and export markets. Management expressed optimism for continued growth, focusing on differentiated products, customer centricity, and operational efficiencies.

    Highlights

    8

    • Revenue grew by 20% YoY to INR957 crores in Q1 FY26.

    • Profit After Tax (PAT) surged by 98% YoY to INR95 crores from INR48 crores in Q1 FY25.

    • EBITDA increased by 56% YoY to INR150 crores, with an EBITDA margin of 15.67%.

    • Crop Care business revenue was up 16% YoY, driven by 13% volume growth.

    • Seed business revenue saw a robust 38% YoY growth, reaching INR305 crores.

    • Soil and Plant Health (SPH) business grew by 33% YoY.

    • Crop Care B2B revenues stood at INR203 crores, with exports component higher by 75% YoY.

    • The company launched 9 new products in Crop Protection B2C and 14 in seeds.

    Key financials

    Single quarter

    04 metrics
    1. 01Revenue₹957 Cr+20%YoY
    2. 02PAT₹95 Cr+98%YoY
    3. 03EBITDA₹150 Cr+56.0%YoY
    4. 04EBITDA Margin15.7%

    Segment breakdown

    Crop Care B2C
    ₹449 Cr Revenue13% Volume Growth
    Soil and Plant Health (SPH)
    33% Growth
    Crop Care B2B
    ₹203 Cr Revenue75% Export Growth23% Volume Growth
    Seed Business
    ₹305 Cr Revenue38% Growth26% EBITDA Margin
    Cotton Seed
    33% Share of Seed Portfolio
    Paddy & Maize Seed
    40% Share of Seed Portfolio
    List

    Guidance & targets

    8
    CategoryTargetPriority
    Capex
    Total Capex Investment
    INR100 crores
    		High
    Profitability
    EBITDA Margin
    15-20%
    		Medium
    Profitability
    Seed Business EBITDA Margin
    20%
    		Medium
    Profitability
    Crop Protection EBITDA Margin
    15%
    		Medium
    Revenue
    Revenue Growth
    high double digit
    		Low
    Capacity
    CSM Manufacturing Opportunity
    INR500 crore
    		Low
    New Products
    Number of New Products (Crop Protection B2C)
    9
    		High
    New Products
    Number of New Products (Seeds)
    14
    		High

    Risks & concerns

    8
    RiskSeverity

    Impact of illegal RRBT cotton on cotton acreage

    The issue of illegal RRBT cotton remains, with a spurt in central India, impacting cotton crop significantly, though Rallis had limited inventory. — Management acknowledged

    medium

    Supply constraints in maize and paddy seeds

    The company faced some processing challenges leading to a little bit of shortage in rice and maize seeds in April and May. — Management acknowledged

    low

    Challenges for Acephate product in Brazil and U.S. markets

    Acephate continues to face challenges in Brazil and U.S., though some revival is seen, and a new formulation is expected to improve margins. — Management acknowledged

    medium

    Monsoon disparities and pest/disease pressure

    Rainfall disparities exist (e.g., Bihar, Northeast less rain), and the build-up of insect, pest, and disease pressure will be critical to watch in August and September. — Management acknowledged

    medium

    Liquidation trends across crop and seed segments

    Liquidation trends need to be closely watched across both crop and seed segments to ensure healthy inventory movement. — Management acknowledged

    medium

    Areas of Evasion(3)

    • Specific revenue contribution from newly launched products
    • Detailed financial breakdown of CSM business due to confidentiality
    • Specific names of all 9 new Crop Protection products

    Q&A highlights

    3

    “So these products have got recently launched, and I don't think we can give you a precise number. Having said that, Prashant, for cotton, I think you are aware that we had some gaps in the Southwest market and we've launched new products. And I would say that most of these products are showing good traction, including the production plan that we have for the subsequent year.”

    Management acknowledged new product launches but deferred specific revenue contribution numbers, indicating early stages of commercialization and a need for more data.

    asked by Prashant, Elara Capital

    2 min read6 chapters

    Detailed Narrative

    01

    Robust Q1 FY26 Financial Performance

    Rallis India reported a strong Q1 FY26, with revenue growing 20% YoY to INR957 crores. Profit After Tax (PAT) saw a significant jump of 98% YoY to INR95 crores, up from INR48 crores in the previous year. EBITDA also increased by 56% YoY to INR150 crores, resulting in an EBITDA margin of 15.67%. This performance was primarily driven by robust volume growth across businesses, indicating an early sign of recovery in the global agrochemical market.

    02

    Segmental Growth Drivers

    The Crop Care business grew 16% YoY, with Crop Care B2C contributing INR449 crores and showing 13% volume-led growth. The Soil and Plant Health (SPH) business expanded by 33%. The Seed business was a standout performer, achieving 38% YoY growth with revenues of INR305 crores, and an EBITDA margin of approximately 26% for the quarter. Crop Care B2B revenues stood at INR203 crores, with exports component growing 75% YoY, benefiting from market recovery and new customer additions.

    03

    Strategic Product Launches and Portfolio Expansion

    The company launched 9 new products in the Crop Protection B2C segment, including 6 herbicides, 2 fungicides, and 1 insecticide, aiming to fill portfolio gaps and strengthen the herbicide category. Additionally, 14 new seed products were introduced. Management expects these new offerings, particularly mixture products, to be large contributors with higher margins, with more specific revenue details anticipated by October.

    04

    Financial Strategy and Margin Outlook

    Management aims for a long-term EBITDA margin in the range of 15% to 20%, with specific targets of 20% for the Seed business and 15% for Crop Protection. The focus is on driving growth to achieve operational efficiencies and absorb fixed costs. The company plans a capex investment of approximately INR100 crores for FY26, primarily for plant upkeep, R&D, and a captive solar plant, while maintaining a healthy cash balance and no external debt.

    05

    Market Dynamics and Key Risks

    The Indian agrochemical market holds a cautiously optimistic outlook, supported by favorable monsoon and higher crop MSPs. However, challenges include the prevalence of illegal RRBT cotton impacting acreage and supply constraints in maize and paddy seeds. The Acephate product continues to face challenges in Brazil and the U.S., though a new dispersible granule formulation is expected to improve its outlook. Management is closely monitoring liquidation trends and monsoon disparities.

    06

    Digital Transformation and Customer Centricity

    Rallis is leveraging digital and artificial intelligence initiatives, such as 'Seedsay' for optimal market placement and 'PlanGuru' for SKU-level forecasting and stocking strategies. These tools are in their second to third year of introduction and are being implemented to enhance operational agility, strengthen customer engagement, and reduce human bias in decision-making, aligning with the strategy to pivot on customer centricity.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.